Methycobal Medilink Pharmaceuticals (Mecobalamin)

Mecobalamin serves as a cofactor for methionine synthase, an enzyme that converts homocysteine to methionine. This reaction is essential for DNA synthesis, myelin formation, and the regeneration of S‑adenosyl‑methionine, thereby supporting red blood cell production and nerve health.

The appropriate dose of Methycobal is determined by a qualified healthcare professional based on the patient’s specific condition, age, weight, and laboratory results. Prescribers set the regimen to achieve optimal therapeutic effect while minimizing risk.

Safety data for mecobalamin in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by the prescribing clinician.

To request Methycobal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both mecobalamin and cyanocobalamin are vitamin B12 analogues, but mecobalamin is a biologically active form that does not require conversion in the body, potentially offering faster utilization. Cyanocobalamin is a synthetic precursor that must be reduced to active forms, which may be less efficient in some patients.

Methycobal should be stored at temperatures below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keeping the product in a dry, cool environment helps maintain its potency throughout its shelf life.

Methycobal is supplied as an oral tablet. It should be swallowed whole with a glass of water, preferably with food to enhance absorption, unless the prescribing clinician advises otherwise.

The most serious adverse reactions include hypersensitivity responses such as anaphylaxis, severe skin eruptions like Stevens‑Johnson syndrome, and significant liver enzyme elevations. Patients should seek immediate medical attention if they experience signs of an allergic reaction or unexplained jaundice.

Methycobal is contraindicated in individuals with a known hypersensitivity to mecobalamin or any excipients in the tablet formulation. Patients with a history of severe allergic reactions to vitamin B12 products should avoid its use.